CTRI/2022/10/046209尚未招募未知
Immunogenecity, Efficacy and Safety of Covishield vaccine in Non- dialysis Chronic Kidney Disease Patients in Comparison with Healthy Subjects; A Clinical Cohort Study.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- JIPMER
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Apparently healthy population with no underlying diseases with age ââ?°Â¥ 18 years.
- •2. Vaccinated or have intent to vaccinate with Cov-ishield according to standard protocol.
- •1.Age ââ?°Â¥ 18 years with Chronic Kidney disease not on dialysis
- •2. Vaccinated or have intent to vaccinate with Cov-ishield according to standard protocol.
排除标准
- •1. Chronic kidney disease patients who are recipi-ents of kidney transplant
- •2. Chronic kidney disease patients with chronic use or high dose steroids or immunosuppresants during the study period.
- •3. Previous known Covid 19 illness.
- •4. People with cocommitant co-morbidities such as autoimmune diseases, liver cirrhosis,Congestive heart failure, cancer and HIV.
- •5. Partially vaccinated individuals.
研究者
相似试验
尚未招募
1 期
CENTAURO-6 StudyLiver NeoplasmsCarcinoma, HepatocellularDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialHepatocellular carcinomaRPCEC00000237Center for Genetic Engineering and Biotechnology (CIGB), in Havana.20
尚未招募
不适用
Immunogenicity and safety COVID-19 vaccine in healthy adults: a single institute based cohort studyCOVID-19JPRN-UMIN000043589Saga University60
进行中（未招募）
不适用
Immunogenicity and safety of COVID-19 vaccines in SLE and rheumatoid arthritis patientsSLERAImmunosuppresive agentsImmunogenicity to SARS-CoV2 vaccinationSLEImmunosuppressive therapyHumoral immune responseCellular immune responseSARS-CoV-2 vaccineRATCTR20210917003Ratchadapiseksompotch Fund, Faculty of Medicine100
已完成
不适用
Safety and immunogenicity of COVID-19 vaccines for SARS-CoV-2 in lung cancer patientsCOVID vaccine in lung cancerCOVID-19 VaccinesCarcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaLung NeoplasmsTCTR20240811003Faculty of Medicine, Chiang Mai University73
尚未招募
1 期
Safety, preliminary efficacy and immunogenicity of traditional Chinese medicine miRNA hydrogel in the treatment of eczema: a randomized, double-blind, placebo-controlled, dose-increasing clinical studyeczemaITMCTR2000003604Shanghai Skin Disease Hospital